Wegovy Lowered Users’ Heart Risks in New Trial
TUESDAY, Aug. 8, 2023 (HealthDay News) — A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect. Taking the medication cut the risk of serious heart problems by 20%, drug maker Novo Nordisk announced Tuesday. “People living with obesity haveContinue Reading










